Google Scholar is a searchable database of academic literature. It connects users with studies and journal articles on nearly any topic of scholarly interest. Google Scholar is free to search, but ...

A phase 3 trial of Scholar Rock’s spinal muscular atrophy (SMA) candidate has hit its primary endpoint, sparking a 200%-plus premarket surge in the biotech’s stock price. Investors went wild despite ...

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein ...

Scholar Rock contends its experimental drug for spinal muscular atrophy can achieve what none of the currently available therapies can do to treat this rare disease. After positive data from a pivotal ...

Scholar Rock's Apitegromab BLA received a CRL due to issues at Catalent Indiana's facility, unrelated to the drug itself. Scholar Rock is working with Catalent to address FDA observations and plans to ...

The Fred Hutch Postbaccalaureate Scholar Program is for individuals who would benefit from research experience and training to ensure that they are competitive when applying to biomedical PhD programs ...